J Chest Surg.
2022 Aug;55(4):357-360. 10.5090/jcs.22.053.
Lung Transplantation for Patients with COVID-19 Acute Respiratory Distress Syndrome
- Cho WH
1,2
- Affiliations
-
- 1Research Institute for Convergence of Biomedical Science and Technology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea
- 2Division of Allergy, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea
- KMID: 2532359
- DOI: http://doi.org/10.5090/jcs.22.053
Abstract
- Patients with severe coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) may exhibit pulmonary fibrosis after the viral illness resolves. Some of these patients may experience severe functional lung impairment, and thus require transplants to prevent death or maintain a tolerable quality of life. Considering the reversibility of COVID-19 ARDS, lung transplant candidates are observed for 1–2 months and must be selected very carefully before transplantation. As the short-term outcomes of such patients are comparable to those of patients with other indications for transplantation, lung transplantation should be actively considered.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Commentary: Referral for Lung Transplantation Should Be Carefully Decided for Patients with COVID-19 Acute Respiratory Distress Syndrome
- Lung transplantation for COVID-19-associated acute respiratory distress syndrome after extended use of extra corporeal membrane oxygenation: a case report
- Early Outcomes of COVID-19 Lung Transplantation Recipients in Korea: A Single-Center Study
- Experience of International Air Transportation and Subsequent Lung Transplant in a Patient with COVID-19-associated Acute Respiratory Distress Syndrome: a Case Report
- Recovery from Acute Respiratory Distress Syndrome with Long-Run Extracorporeal Membrane Oxygenation
